Hold/Accumulate
Fri 21'st Apr 2017

VOLUME
Buy
TREND
Buy
MV LONG
Buy
MV SHORT
Sell
PIVOT
Sell
MACD
Buy
Request Prediction
0.00%
We need your help. Please answer this short survey to help us improve by clicking HERE.

Kite Pharma Stock Analysis

Technical stock analysis for Fri 21'st Apr 2017

Hold candidate since 2017-04-21

Kite Pharma fell by -2.03% in the last day, from USD 81.15 to USD 79.50 The price has been going up and down for this period, and there has been a 3.1% gain for the last 2 weeks. Volume has increased in the last day by 83 632 shares, but on falling prices. This is may be an early warning and the risk will be increased slightly for the next couple of days. In total, 987 768 shares bought and sold for approximately USD 78.53 million.

Trend

Kite Pharma lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at USD 77.51 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 61.7% during the next 3 months and, with 90% probability hold a price between USD 125.31 and USD 167.81 at the end of this period.

Signals

There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Thursday April 20, 2017, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Kite Pharma holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately USD 80.48. On a fall, the stock will find some support from the long-term average at approximately USD 79.15. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Relative Strength Index (RSI)

RSI14 is 53 and the stock is currently not being overbought or oversold

Support & Resistance

Kite Pharma finds support from accumulated volume at USD 78.22, USD 75.10, and USD 70.77. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 79.62, USD 83.98 and USD 81.79.

The stock is about to test the resistance from accumulated volume at USD 79.62 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved USD 2.79 (3.55%) between high and low. For the last week, the stock has had a daily average volatility of 4.46%.

Our recommended stoploss: USD 75.51 (-5.01%) (This stock has low daily movements and this gives low risk. There is a sell signal from pivot top found 1 days ago.)

Evaluation

Kite Pharma holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.

Hold/Accumulate

Feeling LOST?

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Feeling LOST?

Learn To Identify Profitable Stock Chart Patterns.

FREE 7-Day Training

Build Your Watchlist

Add KITE My Watchlist

Recommended
book of the week